Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
Radioembolization Oncology Trial Utilizing Transarterial Eye90 (ROUTE 90) for the Treatment of Hepatocellular Carcinoma (HCC)
Study Status:
Open to Enrollment
Primary Investigator:
Date: November 1, 2024
A Phase 1, Multicenter, Open-Label Study of CB-012, a CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Study Status:
Open to Enrollment
Primary Investigator:
Date: November 26, 2024
A Phase 1b/2 Study of BGB-11417 as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Study Status:
Open to Enrollment
Primary Investigator:
Date: November 26, 2024
Real-world evaluation of the HistoSonics Edison® System for treatment of liver tumors across multidisciplinary users
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 12, 2024
A randomized, double-blind, placebo-controlled study of LMN-201 for prevention of C. difficile infection recurrence (RePreve).
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 13, 2024
A Phase 3, Randomized, Double-Blind, Placebo-Controlled study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 13, 2024
Comprehensive Assessment of Cancer Theranostics Response; Investigating the Intent to Change Treatment Decisions Based on TRAQinform Theranostics
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 13, 2024
Habit Awareness Device for Treatment of Onychophagia
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 13, 2024
Clinical Effect of Caffeine Consumption in Patients Taking Oral Terbinafine
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 17, 2024
Implantation Mycoses in Immunocompromised Patients: a retrospective review of disease course and treatment efficacy
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 13, 2025